Detalhe da pesquisa
1.
Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis.
BMC Cancer;
21(1): 3, 2021 Jan 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33402121
2.
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study.
BMC Cancer;
21(1): 642, 2021 May 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34051732
3.
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
Lancet Oncol;
18(3): 393-403, 2017 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28162999
4.
Societal preferences for adjuvant melanoma health states: UK and Australia.
BMC Cancer;
17(1): 689, 2017 Oct 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29041898
5.
Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma.
Cancer Med;
12(3): 2378-2388, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35880244
6.
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.
Oncologist;
17(11): 1376-85, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23024154
7.
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment.
Health Qual Life Outcomes;
10: 66, 2012 Jun 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22694829
8.
Cost-Utility of Nivolumab Plus Ipilimumab in First-Line Treatment of Advanced Melanoma in the United States: An Analysis Using Long-Term Overall Survival Data from Checkmate 067.
Pharmacoecon Open;
6(5): 697-710, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36006606
9.
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma.
MDM Policy Pract;
7(1): 23814683221089659, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35356551
10.
Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma.
Eur J Cancer;
158: 225-233, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34663559
11.
Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma.
Eur J Cancer;
132: 176-186, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32380428
12.
Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection.
Pharmacoecon Open;
4(2): 343-351, 2020 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31587138
13.
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors.
Eur J Cancer;
137: 171-174, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32777716
14.
Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Appl Health Econ Health Policy;
7(1): 31-41, 2009.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19558193
15.
Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma.
Exp Hematol Oncol;
8: 14, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31312536
16.
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy.
J Natl Cancer Inst;
110(1)2018 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28922786
17.
An expanded portfolio of survival metrics for assessing anticancer agents.
Am J Manag Care;
23(1): 54-61, 2017 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28141932
18.
Health-related quality of life results from the phase III CheckMate 067 study.
Eur J Cancer;
82: 80-91, 2017 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28651159
19.
Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.
Infect Control Hosp Epidemiol;
27(11): 1226-32, 2006 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17080381
20.
Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study.
Cancer Med;
5(7): 1436-43, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27118102